20 June 2013
Keywords: levemir, demonstrates, safety, efficacy, danish, drugmaker, novo
Article | 07 February 2007
Danish drugmaker Novo Nordisk says that the results of a trial of Levemir (insulin detemir [rDNA origin] injection) are a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 February 2007
5 February 2007
19 June 2013
© 2013 thepharmaletter.com